Myocarditis with very high troponins: risk stratification by cardiac magnetic resonance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases.Journal of cancer research and clinical oncology · 2019
   Pooled it
2. Impact of Early Diagnosis and Immunosuppressive Therapy on Giant Cell Myocarditis Outcomes: A Review.Life (Basel, Switzerland) · 2026
   Review
3. Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up.Rheumatology and immunology research · 2024
   Article
4. Quantification of hs-Troponin Levels and Global Longitudinal Strain among Critical COVID-19 Patients with Myocardial Involvement.Journal of clinical medicine · 2024
   Article
5. Optimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review.Diagnostics (Basel, Switzerland) · 2023
   Review
6. PD-1 inhibitors-associated myocarditis in non-small cell lung cancer patients.Journal of thoracic disease · 2023
   Article
7. Clinical outcome of established diagnostic and treatment modalities of COVID-19-associated myocarditis: a systematic review.Annals of medicine and surgery (2012) · 2023
   Article
8. Analysis of clinical characteristics of mesalazine-induced cardiotoxicity.Frontiers in pharmacology · 2022
   Article
9. The role of antibody-based troponin detection in cardiovascular disease: A critical assessment.Journal of immunological methods · 2021
   Review
10. Case report: high-grade atrioventricular block in suspected COVID-19 myocarditis.European heart journal. Case reports · 2020
    Article
11. Clinical manifestation and management of immune checkpoint inhibitor-associated cardiotoxicity.Thoracic cancer · 2020
    Review

Corrections and comments

• Comment on
  Myocarditis with chest pain, normal heart function and extreme increased troponin.2016

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.